We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Racial Disparity in Colorectal Cancer Related to Healthcare Utilization

By HospiMedica International staff writers
Posted on 19 May 2010
A new study has found that black patients who underwent flexible sigmoidoscopy were less likely to schedule recommended follow-up colonoscopy than white patients, which may lead to higher rates of colorectal cancer (CC) mortality.

Researchers at Howard University (Washington, DC, USA) reviewed the U.S. More...
Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) screening trial to explore the origins of racial disparities in CC. In all, data from 57,561 white patients and 3,011 black patients (ages 55 to 74) that underwent flexible sigmoidoscopy without biopsy were included. Polyps or mass lesions were found in 25.5% of blacks and 23.9% of whites; all were advised to get a follow-up colonoscopy, which was not paid for by the trial. Of those, 72.4% of whites and 62.6% of blacks had a colonoscopy within one year.

The study investigators reviewed the results and found no significant difference between the races in the prevalence of polyps, advanced adenomas, advanced pathology in small adenomas, or CC. After adjustment for age, education, sex, body mass index, smoking, family history of CC, colon examination within the previous three years, personal history of polyps, and screening center, blacks were 12% less likely to have a colonoscopy. There were no other significant differences based on race in the characteristics of the lesions found during colonoscopy. The study was published in the April 21, 2010, issue of the Journal of the National Cancer Institute.

"This suggests that the biology of colorectal cancer may not be materially different by race, at least in the early stages of carcinogenesis, but instead that healthcare utilization differences among the races may play a more important role in the observed disparities in colorectal cancer,” concluded lead author Adeyinka Laiyemo, M.D., M.P.H., and colleagues of the division of gastroenterology. "A lack of knowledge of cancer prevention may contribute to low uptake of diagnostic testing, and lack of cultural competence on the part of care providers may also constitute a barrier to healthcare utilization.”

Related Links:

Howard University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.